SCHEMBL8300824

SCHEMBL8300824

N#Cc1ccc(F)c(F)c1CC(=O)O

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.41
RXRB P28702 1/20 0.41
RXRG P48443 1/20 0.41
PTGDR2 Q9Y5Y4 2/20 0.38
FFAR1 O14842 1/20 0.35
FFAR4 Q5NUL3 1/20 0.35
AKR1B1 P15121 1/20 0.35
TRPV4 Q9HBA0 1/20 0.34
CRHBP P24387 1/20 0.34
CRHR2 Q13324 1/20 0.34
CNR2 P34972 1/20 0.34
F2 P00734 3/20 0.34
SLC22A12 Q96S37 2/20 0.33
S1PR1 P21453 1/20 0.33
S1PR3 Q99500 1/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
MAP3K8 P41279 1/20 0.33
MRGPRX4 Q96LA9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24495512 0.83 AKR1B1 (0.41) RXRARXRBRXRGPTGDR2FFAR1
SCHEMBL31446897 0.79 AKR1B1 (0.43) RXRARXRBRXRGPTGDR2AKR1B1
SCHEMBL909585 0.79 AKR1B1 (0.43) FFAR4AKR1B1CES2CES1
SCHEMBL29459948 0.79 AKR1B1 (0.43) FFAR4AKR1B1CES2CES1
SCHEMBL3888694 0.79 KDM4E (0.45)
Hydrochloric Acid SCHEMBL1372127 0.77 AKR1B1 (0.42) FFAR4AKR1B1CES2CES1
SCHEMBL2722804 0.76 RXRA (0.38) RXRARXRBRXRGPTGDR2FFAR1
SCHEMBL13804127 0.74 TRPV4 (0.38) TRPV4
SCHEMBL15196732 0.74 RXRA (0.42) RXRARXRBRXRGFFAR1FFAR4
SCHEMBL7369555 0.73 IMPDH2 (0.44) RXRARXRBRXRGPTGDR2S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613319-B1 SUBSTITUTED PHENYL ACETAMIDES AND THEIR USE AS PROTEASE INHIBITORS ORTHO MCNEIL PHARM INC (US) 2009-06-03 EP disclosed
WO-2004091613-A2 SUBSTITUTED PHENYL ACETAMIDES AND THEIR USE AS PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2004-10-28 WO disclosed